Type Whole antibody ATC code none ChemSpider none | CAS Number 219649-07-7 | |
Target | ||
Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer. It selectively binds to carcinoembryonic cell adhesion molecule 5.
This drug was developed by Immunomedics, Inc.
References
Labetuzumab Wikipedia(Text) CC BY-SA